Arcutis Biotherapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Arcutis Biotherapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • Arcutis Biotherapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $216M, a 32.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $216M +$53.4M +32.8% Dec 31, 2023 10-K 2024-02-27
Q4 2022 $163M +$72.4M +80.1% Dec 31, 2022 10-K 2024-02-27
Q4 2021 $90.4M +$44.7M +98.1% Dec 31, 2021 10-K 2023-02-28
Q4 2020 $45.6M +$30.7M +206% Dec 31, 2020 10-K 2022-02-22
Q4 2019 $14.9M Dec 31, 2019 10-K 2021-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.